Български
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Gut Microbiome and Obesity

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Линкът е запазен в клипборда
СъстояниеНабиране
Спонсори
Federico II University

Ключови думи

Резюме

Pediatric obesity is a risk factor for the onset of obesity in adulthood and is a risk factor for various chronic non-communicable diseases. Metabolic syndrome (MS) is the name for a group of risk factors that increase cardiovascular risk and other health problems characterized by the presence of abdominal obesity, dyslipidemia, hyperglycaemia and high blood pressure. Numerous preclinical and clinical data suggest a potential role of the intestinal microbiota in these diseaes. Unfortunately, comparative studies of the gut microbiota are still scarce in pediatric subjects suffering from obesity than obesity complicated by MS. The aim is to study the metagenomics and metabolomics characteristics of the intestinal microbiota in obese children/adolescents with or without MS, that could provide useful data for innovative intervention strategies for these conditions.

Дати

Последна проверка: 06/30/2020
Първо изпратено: 06/24/2020
Очаквано записване подадено: 06/24/2020
Първо публикувано: 06/29/2020
Изпратена последна актуализация: 06/30/2020
Последна актуализация публикувана: 07/06/2020
Действителна начална дата на проучването: 04/30/2020
Приблизителна дата на първично завършване: 04/30/2022
Очаквана дата на завършване на проучването: 04/30/2022

Състояние или заболяване

Obesity, Childhood
Metabolic Syndrome

Интервенция / лечение

Other: Obese with or without metabolic syndromesubjects

Фаза

-

Групи за ръце

ArmИнтервенция / лечение
Obese subjects
Subjects with obesity
Obese plus metabolic syndrome subjects
Subjects with obesity and metabolic syndrome
Healthy controls
Otherwise healthy subjects

Критерии за допустимост

Възрасти, отговарящи на условията за проучване 10 Years Да се 10 Years
Полове, допустими за проучванеAll
Метод за вземане на пробиProbability Sample
Приема здрави доброволциНе
Критерии

Inclusion Criteria:

- Subjects aged between 10-16 years,

- diagnosis of obesity or obesity complicated by metabolic syndrome

- healthy controls

Exclusion Criteria:

- Age at enrollment < 10 or >16 years,

- concomitant presence of chronic diseases,

- neoplasms,

- immunodeficiencies,

- chronic infections,

- autoimmune diseases,

- chronic inflammatory bowel diseases,

- celiac disease, -genetic-metabolic diseases, -

- cystic fibrosis

- chronic lung diseases,

- malformations of the cardiovascular/respiratory/gastrointestinal system,

- neuropsychiatric disorders

- neurological pathologies,

- assumption of antibiotics and/or pre/pro/synbiotics

- onset of diarrhea or acute gastrointestinal disease during the 12 weeks prior to enrollment.

Резултат

Първични изходни мерки

1. Concentration of metagenomic characteristics of the intestinal microbiota in subjects with obesity, obesity complicated by metabolic syndrome and healthy controls [at enrollment]

Evaluation of gut microbiota composition

Вторични изходни мерки

1. Concentration of metabolomic characteristics of the intestinal microbiota in subjects with obesity, obesity complicated by metabolic syndrome and healthy controls [at enrollment]

Evaluation of butyrate

2. Concentration of the metabolomic characteristics of the intestinal microbiota in subjects with obesity, obesity complicated by metabolic syndrome and healthy controls [at enrollment]

Evaluation of acetate

3. Concentration of the metabolomic characteristics of the intestinal microbiota in subjects with obesity, obesity complicated by metabolic syndrome and healthy controls [at enrollment]

Evaluation of propionate

4. Concentration of the metabolomic characteristics of the intestinal microbiota in subjects with obesity, obesity complicated by metabolic syndrome and healthy controls [at enrollment]

Evaluation of indole

Присъединете се към нашата
страница във facebook

Най-пълната база данни за лечебни билки, подкрепена от науката

  • Работи на 55 езика
  • Билкови лекове, подкрепени от науката
  • Разпознаване на билки по изображение
  • Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
  • Прочетете научни публикации, свързани с вашето търсене
  • Търсете лечебни билки по техните ефекти
  • Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите

Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания

Google Play badgeApp Store badge